The development of strong pruritus after intravenous application of hy
droxyethyl starch (HES) has been repeatedly observed in the last years
, especially in otorhinolaryngology. The characteristics of this disea
se are summarized by a review of the literature. Typically generalised
pruritus without visible skin lesions (>>sine materia<<) develops wit
hin 1 to 3 weeks after application of HES. As a rule there is spontane
ous remission of itching. The incidence of pruritus increases with the
cumulative dosage and depends on the biochemical properties of the in
fused type of HES. Tissue storage of HES in the skin is very likely to
be responsible for the itching, allergic mechanisms are of minor impo
rtance. In cases with a typical history and clinical picture it is not
justified to carry out extensive allergologic tests. The pruritus can
hardly be influenced and resists to therapy with antihistaminic drugs
or glucocorticosteroids. It is important to avoid well-known provocat
ive factors such as mechanical irritation and heat.